Jain Sajal, Buttar Harpal S, Chintameneni Meena, Kaur Ginpreet
Department of Pharmaceutical Sciences, Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM`S NMIMS, Mumbai- 400056, India.
Department of Pathology and Laboratory Medicine, University of Ottawa, School of Medicine, Ottawa, Ontario, Canada.
Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):145-157. doi: 10.2174/1872213X12666180815144803.
Inflammation-induced endothelial abnormalities, dietary habits, and tobacco smoking are considered to be the primary risk factors for causing atherosclerosis and Cardiovascular Diseases (CVDs), including Coronary Heart Disease (CHD), cerebrovascular disorders, peripheral arterial disease, rheumatic heart disease, congenital heart defects, deep vein thrombosis and pulmonary embolism. Prevention of CVDs with anti-inflammatory and anti-oxidant agents has been a challenging task for decades. Currently, CVDs have taken a top position among the health-related issues and are considered the foremost cause of mortality and morbidity around the globe.
Emerging evidence from several sources indicates that nutraceuticals and plant products may be a cost-effective approach for the prevention of CVDs. A limited number of clinical studies done with nutraceuticals have shown positive effects for promoting health and well-being as well as reduction of CVDs in humans. Some plants from which nutraceutical ingredients are isolated and will be discussed in this review are: Murraya koenigii, Curcuma longa, Beta vulgaris, Allium sativum, Allium cepa, Lagenaria siceraria Stand, Trigonella foenum-graecum.
Literature searches were done using keywords for plants, nutraceuticals, and plant products that have revealed beneficial effects in the prevention of CVDs. The anti-oxidant and anti-inflammatory actions of nutraceuticeuticals and plant ingredients play a significant role in capturing free radicals and reducing endothelial risk factors associated with the occurrence CVDs.
This review has explored the usefulness of animal studies performed with nutraceuticals and herbal products and to understand their mode of action in the prevention of CVDs. Also, we have referred to patents for different nutraceuticals for better understanding their quantitative effects and dosage forms.
It is concluded that nutraceuticals possess enormous health benefits and their interventions can be highly beneficial in the prevention/reduction of CVDs and related disorders such as atherosclerosis, hypertension, heart attack and stroke. The findings of this review provide an update on the emerging uses of nutraceuticals, functional foods, and herbal remedies in humans. Nevertheless, large-scale randomized, placebo-controlled, double-blind clinical trials are needed to confirm the health benefit claims about nutraceuticals and herbal products to establish their long-term safety and to resolve the controversy about the role of clinical nutrition in curing lifestyle diseases.
炎症诱导的内皮异常、饮食习惯和吸烟被认为是导致动脉粥样硬化和心血管疾病(CVD)的主要危险因素,包括冠心病(CHD)、脑血管疾病、外周动脉疾病、风湿性心脏病、先天性心脏缺陷、深静脉血栓形成和肺栓塞。几十年来,用抗炎和抗氧化剂预防心血管疾病一直是一项具有挑战性的任务。目前,心血管疾病在与健康相关的问题中占据首位,被认为是全球死亡和发病的首要原因。
来自多个来源的新证据表明,营养保健品和植物产品可能是预防心血管疾病的一种经济有效的方法。对营养保健品进行的有限数量的临床研究表明,其对促进健康和幸福以及降低人类心血管疾病具有积极作用。本文将讨论从中分离出营养成分的一些植物:印度楝、姜黄、甜菜、大蒜、洋葱、瓠瓜、胡芦巴。
使用在预防心血管疾病方面具有有益作用的植物、营养保健品和植物产品的关键词进行文献检索。营养保健品和植物成分的抗氧化和抗炎作用在捕获自由基和降低与心血管疾病发生相关的内皮危险因素方面发挥着重要作用。
本综述探讨了用营养保健品和草药产品进行动物研究的有用性,并了解它们在预防心血管疾病中的作用模式。此外,我们还参考了不同营养保健品的专利,以更好地了解它们的定量效果和剂型。
得出的结论是,营养保健品具有巨大的健康益处,其干预措施在预防/减少心血管疾病及相关疾病如动脉粥样硬化、高血压、心脏病发作和中风方面可能非常有益。本综述的结果提供了营养保健品、功能性食品和草药疗法在人类中新出现用途的最新信息。然而,需要大规模的随机、安慰剂对照、双盲临床试验来证实关于营养保健品和草药产品的健康益处声明,以确定它们的长期安全性,并解决临床营养在治疗生活方式疾病中的作用的争议。